Clinical Trials Directory

Trials / Unknown

UnknownNCT05852327

Risk Stratifying COPD Exacerbations

Risk Stratifying COPD Exacerbations: a Prospective Study

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Pamela Youde Nethersole Eastern Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

To identify clinical characteristics on presentation which predict differential outcomes in patients with exacerbation of COPD.

Detailed description

Exacerbations of COPD (ECOPD) are heterogenous but are often considered as a single clinical entity. Clinical characteristics on presentation may predict outcome of patients with ECOPD. DECAF score was previously proposed to predict in-hospital mortality but has not been validated in Asian subjects. ROME classification was recently proposed to better risk stratify ECOPD according to symptoms, physiological parameters and laboratory findings on admission, but no prospective validation study is available so far. This study aims to identify clinical characteristics on presentation to predict outcome of patients with ECOPD.

Conditions

Interventions

TypeNameDescription
OTHERObservation onlyObservation only

Timeline

Start date
2023-02-01
Primary completion
2024-02-01
Completion
2025-02-01
First posted
2023-05-10
Last updated
2023-12-27

Locations

2 sites across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT05852327. Inclusion in this directory is not an endorsement.

Risk Stratifying COPD Exacerbations (NCT05852327) · Clinical Trials Directory